Product review of DrugPatentWatch (sources - content & coverage)
Jinfo Article
22nd January 2018
By Scott Vine
Abstract
In part two of our product review of DrugPatentWatch, a database which provides patent information from the US and worldwide along with other actionable business intelligence on small-molecule drugs, we take a look at its strengths and weaknesses and content and sources.
Note: Full review (PDF) at /go/sub/report/2934
Content Access
Access to Jinfo Content and Community is available through a Jinfo Subscription.
Does your organisation have a Jinfo Subscription?
"Not yet"
Access to this article is available through a Jinfo Subscription, which will help your organisation:
- Save time and money
- Re-invent information services
- Define, measure and communicate information value.
"Don't know"
Contact us to find out if your organisation already has a Jinfo Subscription.
Or use the 'Text Chat' button at the bottom-right of this page for immediate assistance.
- Article title: Product review of DrugPatentWatch (sources - content & coverage)
- Link to this page
- View printable version
- Product review of DrugPatentWatch (value - help & training; competitors; development; pricing)
Wednesday, 24th January 2018 - Product review of DrugPatentWatch (technology - search & user interface; outputs & alerts; administration)
Tuesday, 23rd January 2018 - Product review of DrugPatentWatch (key advantages; introduction; contact details)
Friday, 19th January 2018 - Mini review of AdisInsight - a "one-stop solution" for pharmaceutical researchers
Wednesday, 15th March 2017
- Product review of DrugPatentWatch
Friday, 19th January 2018
Vendor adoption of AI
Community session
23rd May 2024
Mainstream GenAI, emerging vendors and your offshore resourcing strategy
Blog posting
9th May 2024
May 2024 Update
YouTube video
9th May 2024
- Jinfo Community session (TBC) (Community) 16th July 2024
- Jinfo Community session (TBC) (Community) 18th June 2024
- Vendor adoption of AI (Community) 23rd May 2024